RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)
CUSIP: 75629V104
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Class A Common Stock
- Shares outstanding
- 514,715,255
- Total 13F shares
- 94,346,907
- Share change
- +18,361,677
- Total reported value
- $1,616,473,942
- Put/Call ratio
- 63%
- Price per share
- $17.13
- Number of holders
- 122
- Value change
- +$295,962,917
- Number of buys
- 94
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75629V104:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
89%
|
339,055,144
|
$3,929,649,000 | — | 30 Sep 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
—
mixed-class rows
|
113,064,184
mixed-class rows
|
$1,562,354,000 | — | 30 Sep 2021 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
30%
|
114,886,852
|
$1,331,539,000 | — | 30 Sep 2021 | |
| Senator Investment Group LP |
13F
|
Company |
21%
|
78,703,273
|
$912,171,000 | — | 30 Sep 2021 | |
| Anchorage Capital Group, L.L.C. |
13F
|
Company |
18%
|
67,151,368
|
$778,284,000 | — | 30 Sep 2021 | |
| ARK Investment Management LLC |
13F
|
Company |
—
mixed-class rows
|
25,824,691
mixed-class rows
|
$328,930,000 | — | 30 Sep 2021 | |
| Lux Ventures IV, L.P. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
13,021,519
|
$137,710,376 | — | 07 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
11,284,123
mixed-class rows
|
$130,893,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.2%
|
8,550,100
|
$99,095,000 | — | 30 Sep 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
—
mixed-class rows
|
7,750,964
mixed-class rows
|
$96,094,000 | — | 30 Sep 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.76%
|
3,923,713
|
$90,285,000 | — | 30 Sep 2021 | |
| Telemark Asset Management, LLC |
13F
|
Company |
1.6%
|
6,000,000
|
$69,540,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.53%
|
2,711,980
|
$62,403,000 | — | 30 Sep 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
—
mixed-class rows
|
4,961,877
mixed-class rows
|
$62,182,000 | — | 30 Sep 2021 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
—
mixed-class rows
|
4,961,877
mixed-class rows
|
$61,359,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.38%
|
1,959,963
|
$45,099,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.34%
|
1,767,659
|
$40,673,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.32%
|
1,644,494
|
$37,840,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.32%
|
1,639,341
|
$37,721,000 | — | 30 Sep 2021 | |
| Bain Capital Public Equity Management II, LLC |
13F
|
Company |
0.79%
|
3,039,000
|
$35,222,000 | — | 30 Sep 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.78%
|
3,000,000
|
$34,770,000 | — | 30 Sep 2021 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.29%
|
1,509,254
|
$34,728,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.28%
|
1,450,596
|
$33,379,000 | — | 30 Sep 2021 | |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC |
13F
|
Company |
0.27%
|
1,388,889
|
$31,958,000 | — | 30 Sep 2021 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.68%
|
2,617,826
|
$30,340,000 | — | 30 Sep 2021 | |
| TIGER GLOBAL MANAGEMENT LLC |
13F
|
Company |
0.63%
|
2,425,000
|
$28,106,000 | — | 30 Sep 2021 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.62%
|
2,381,270
|
$27,599,000 | — | 30 Sep 2021 | |
| ALLEN OPERATIONS LLC |
13F
|
Company |
—
mixed-class rows
|
2,251,595
mixed-class rows
|
$26,874,000 | — | 30 Sep 2021 | |
| Comprehensive Financial Management LLC |
13F
|
Company |
0.22%
|
1,109,395
|
$25,527,000 | — | 30 Sep 2021 | |
| Chescapmanager LLC |
13F
|
Company |
0.52%
|
2,000,000
|
$23,180,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.17%
|
895,860
|
$20,614,000 | — | 30 Sep 2021 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.43%
|
1,646,853
|
$19,087,000 | — | 30 Sep 2021 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
0.45%
|
1,729,791
|
$17,643,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
1,511,459
|
$17,518,000 | — | 30 Sep 2021 | |
| SPRUCE HOUSE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.39%
|
1,500,000
|
$17,385,000 | — | 30 Sep 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.15%
|
752,939
|
$17,325,000 | — | 30 Sep 2021 | |
| CRV, LLC |
13F
|
Company |
0.14%
|
733,986
|
$16,889,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
—
mixed-class rows
|
872,570
mixed-class rows
|
$16,744,000 | — | 30 Sep 2021 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.14%
|
695,800
|
$16,010,000 | — | 30 Sep 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.13%
|
661,703
|
$15,226,000 | — | 30 Sep 2021 | |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,388,889
|
$14,688,335 | — | 01 Nov 2021 | |
| Trybe Capital Management LP |
13F
|
Company |
0.32%
|
1,207,992
|
$14,001,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
562,331
|
$12,939,000 | — | 30 Sep 2021 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
548,455
|
$12,620,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
1,042,313
|
$11,993,000 | — | 30 Sep 2021 | |
| Kamunting Street Capital Management, L.P. |
13F
|
Company |
0.26%
|
998,664
|
$11,575,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.1%
|
500,000
|
$11,505,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.23%
|
894,188
|
$10,364,000 | — | 30 Sep 2021 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
—
mixed-class rows
|
473,530
mixed-class rows
|
$10,039,000 | — | 30 Sep 2021 | |
| PointState Capital LP |
13F
|
Company |
0.08%
|
409,567
|
$9,424,000 | — | 30 Sep 2021 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q4 2021
As of 31 Dec 2021,
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,346,907 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Obvious Management Services, L.L.C., Data Collective IV GP, LLC, STATE STREET CORP, DCVC Opportunity Fund II GP, LLC, Laurion Capital Management LP, ALLIANCEBERNSTEIN L.P., and ARK Investment Management LLC.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
82
Q4 2021 holders
122
Holder diff
40
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.